SM
Schoenberg Mark Directeur Médical
Other M
US US · SEC (Form 4)
€3,703
▲ Purchases (2 ops.)
Discover the full record of transactions filed by Schoenberg Mark, Directeur Médical. Director active across 1 companies, notably UroGen Pharma Ltd.. In total, 17 reports have been recorded. Total volume traded: €4k. The latest transaction was disclosed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 17 total
500 shares
Ordinary Shares
SEC:0001437749-22-010701:0 · 30 Apr 2022
500 shares
Ordinary Shares
SEC:0001209191-22-006384 · 31 Jan 2022
500 shares
Ordinary Shares
SEC:0001209191-22-006384:0 · 31 Jan 2022
209 shares
Ordinary Shares
SEC:0001209191-22-005416 · 26 Jan 2022
209 shares
Ordinary Shares
SEC:0001209191-22-005416:0 · 26 Jan 2022
€1,851 160 shares @ €11.5712 0.0001% mcap 100.0% of flow
Ordinary Shares
SEC:0001209191-21-065756 · 18 Nov 2021
Ideal exit: 15 Aug 2022 (T+270) €1,851 160 shares @ €11.5712 0.0001% mcap 50.0% of flow
Ordinary Shares
SEC:0001209191-21-065756:0 · 18 Nov 2021
Ideal exit: 15 Aug 2022 (T+270) 500 shares
Ordinary Shares
SEC:0001209191-21-062360 · 31 Oct 2021
500 shares
Ordinary Shares
SEC:0001209191-21-062360:0 · 31 Oct 2021
208 shares
Ordinary Shares
SEC:0001209191-21-061868 · 26 Oct 2021
208 shares
Ordinary Shares
SEC:0001209191-21-061868:0 · 26 Oct 2021
500 shares
Ordinary Shares
SEC:0001209191-21-049477 · 31 Jul 2021
500 shares
Ordinary Shares
SEC:0001209191-21-049477:0 · 31 Jul 2021
208 shares
Ordinary Shares
SEC:0001209191-21-048398 · 26 Jul 2021
208 shares
Ordinary Shares
SEC:0001209191-21-048398:0 · 26 Jul 2021
500 shares
Ordinary Shares
SEC:0001209191-21-029758 · 30 Apr 2021
500 shares
Ordinary Shares
SEC:0001209191-21-029758:0 · 30 Apr 2021
About Schoenberg Mark Mark Schoenberg is an executive at UroGen Pharma Ltd.